SeterusnyaPanduan seterusnya
Perisian sebagai Peranti Perubatan (SaMD)
Masyarakat
PANDUAN Masyarakat
AI medical devices in Europe may be subject to the Medical Device Regulation and, when applicable, the EU AI Act.
Dengar panduan iniAI-diceritakan · ~3 min
The rules depend on the device’s intended purpose, risk class, role of the AI system, and applicable transition dates. Manufacturers and deployers should assess both frameworks, document conformity evidence, and verify current guidance rather than assume AI replaces MDR obligations.
The EU Medical Device Regulation (MDR) sets requirements for medical devices placed on the European market, including clinical evaluation, risk management, quality systems, and conformity assessment. AI Act obligations may also apply when an AI system is embedded in or constitutes a medical device covered by the MDR and the relevant conformity assessment involves a notified body. The relationship is not a blanket rule that every AI tool has the same classification or deadline. Classification depends on intended purpose and device characteristics under MDR rules. The AI Act separately defines high-risk categories and imposes requirements such as risk management, data governance, technical documentation, logging, transparency, human oversight, accuracy, and cybersecurity where applicable. European Commission MDCG 2025-6 addresses the interaction between MDR/IVDR and the AI Act. Applicability dates have transition provisions; the Commission’s current AI Act information states that high-risk AI embedded in regulated products has an extended application date of 2 August 2028 under current rules. Organizations should determine which legal role they have, identify the device and AI system boundaries, map existing conformity assessments, and track harmonized standards and guidance. Verify current legal text and transition dates because amendments and guidance can change obligations. This guide is an orientation, not a device classification decision or legal opinion. Sponsors should document assumptions, responsible legal entities, and how software updates affect the device’s intended purpose. A standalone administrative tool may be treated differently from AI that drives a medical-device function, so classification cannot be inferred from model type alone.
A manufacturer maps an AI-enabled diagnostic device’s intended purpose to MDR classification and AI Act requirements.
A compliance team checks whether the AI system is a safety component or product subject to third-party conformity assessment.
A hospital reviews provider documentation and human oversight before deployment.
A regulatory group tracks transition dates and updates its compliance plan.
The MDR and AI Act frameworks will continue to develop through implementing rules, standards, and guidance. Manufacturers should monitor Commission and MDCG publications and plan for documentation and quality-system needs before transition periods expire. Hospitals should ask suppliers for clear conformity and oversight information. The regulatory result depends on the specific device, intended use, and current legal text. Providers and deployers should coordinate so human oversight and incident reporting are clear throughout the device lifecycle. Keep a named owner for periodic reassessment.
Newsletter percuma
Tiga cerita AI yang disahkan setiap pagi hari bekerja, ditulis dalam Bahasa Inggeris biasa. Percuma selamanya, tiada iklan.
Satu e-mel setiap hari bekerja. Berhenti melanggan dalam satu klik. Kami tidak pernah menjual atau berkongsi alamat anda.
Uji diri anda
Maklum balas segera pada setiap jawapan, dan sijil yang boleh dikongsi dengan ID yang boleh disahkan sebaik sahaja anda lulus kursus.
Sokong pendidikan AI percuma. AI Understanding ialah pertubuhan bukan keuntungan 501(c)(3) — tiada iklan, tiada bayaran dinding, selamanya. Buat derma
AI medical devices in Europe may be subject to the Medical Device Regulation and, when applicable, the EU AI Act. The rules depend on the device’s intended purpose, risk class, role of the AI system, and applicable transition dates. Manufacturers and deployers should assess both frameworks, document conformity evidence, and verify current guidance rather than assume AI replaces MDR obligations.
The frameworks depend on product scope and risk classification.
MDR requirements apply to medical devices according to their scope.
Applicability depends on AI Act definitions and assessment route.
Teruskan belajar
Lebih banyak panduan dipilih untuk topik ini
SeterusnyaPanduan seterusnya
Perisian sebagai Peranti Perubatan (SaMD)
Masyarakat